Progressive Encephalomyelopathy in an Older Man: A Case Report From the National Multiple Sclerosis Society Case

Lindsay A Ross1, Jonathan Lee1, Alise K Carlson1

  • 1From the Mellen Center for Multiple Sclerosis Treatment and Research (L.A.R., A.K.C., D.S.C., J.A.C., A.K.) and Diagnostic Radiology (J.L.), Cleveland Clinic, OH; Department of Neurosciences (J.G.), University of California San Diego, La Jolla, CA; UCSF Weill Institute of Neurosciences (S.S.Z.), University of California at San Francisco; and Department of Neurology (S.D.N.), Johns Hopkins School of Medicine, Baltimore, MD.

Insights

This case study describes a 77-year-old man with progressive encephalomyelopathy. Spinal MRI revealed symmetric lateral column abnormalities, leading to a presumptive diagnosis and discussion of disease immunopathogenesis.

Area of Science:

  • Neurology
  • Neuroimmunology
  • Radiology

Background:

  • Subacute encephalomyelopathy presents a diagnostic challenge, often requiring advanced imaging and consideration of immune-mediated processes.
  • Progressive neurological deficits necessitate a thorough differential diagnosis to identify underlying causes.
  • Spinal magnetic resonance imaging (MRI) is crucial for evaluating white matter abnormalities in the central nervous system.

Observation:

  • A 77-year-old male presented with subacute onset of progressive neurological symptoms.
  • Spinal MRI demonstrated characteristic symmetric signal abnormalities within the lateral columns.
  • The clinical presentation and imaging findings prompted further investigation into potential etiologies.

Findings:

  • The case highlights symmetric lateral column signal abnormalities on spinal MRI as a key diagnostic indicator.
  • Differential diagnoses for such findings were considered, including inflammatory, infectious, and degenerative conditions.
  • A presumptive diagnosis was established, supported by the review of the disease's immunopathogenesis.

Implications:

  • This case underscores the importance of spinal MRI in diagnosing encephalomyelopathies with specific white matter patterns.
  • Understanding the immunopathogenesis is critical for developing targeted therapies for similar conditions.
  • The findings contribute to the clinical knowledge base for rare neurological disorders and their management.